Understanding complex biology through AI
We integrate the best of human and artificial intelligence to deliver better drugs and diagnostics at scale
Understanding complex biology through AI
We are a full-stack AI biotech
By understanding complex biology through AI, we identify new treatments, de-risk and accelerate clinical trials, and build diagnostic tools to reduce time to impact for patients.
Multimodal patient data
Owkin works with top academic centers to curate, enrich and generate deep, multimodal data that is AI ready.
We are building a technology platform called Abstra that will host a metadata catalog to enable researchers and data scientists to discover collaborators and datasets, enhancing and expediting AI biomedical research.
Subgroup discovery
We apply AI to multimodal, KOL-curated data to subtype patients and identify novel biomarkers to inform drug discovery, de-risk clinical trials and develop and deploy diagnostics in clinical practice.
AI drug discovery
Our drug discovery engines leverage our expertise in AI, biology, and medicine to understand the intricate biological interactions that define specific patient subgroups. Through our AI engines, we deliver novel drug targets and optimize drug positioning.
AI drug development
We combine machine learning methodologies, patient data, and innovative modalities to increase the probability of success of clinical trials.
AI diagnostics
Our AI diagnostics help pre-screen for biomarkers, and predict outcomes — giving healthcare providers a fuller picture of a patient’s disease. This means more patients can benefit from targeted therapies.
Why work with Owkin
Sanofi - AI drug discovery
BMS - AI drug development
We are hiring
Join our team
We are a community of diverse people bringing our energy and skills to find the right treatment for every patient.